## CI: The Cigna Group - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.56 indicates fundamental undervaluation. Quality metrics strong (ROE 16%). Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-4.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($250.28)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. TKO Group Lifts Quarterly Dividend to $0.78 per Class A Share, Payable Dec. 30 to Holders of Record as of Dec. 15**
- Source: MarketScreener | 20251204T140858 | Somewhat-Bullish | Relevance: 72%
- TKO Group Holdings, Inc. has announced an increase in its quarterly dividend to $0.78 per Class A share. This dividend is payable on December 30, 2025, to shareholders of record as of December 15, 2025. The announcement was made on December 4, 2025, at 08:49 am EST.

**2. Bernstein Adjusts Price Target on Cummins to $544 From $475, Maintains Market Perform Rating**
- Source: marketscreener.com | 20251205T131510 | Neutral | Relevance: 63%
- Bernstein has raised its price target for Cummins (CMI) to $544 from $475, while maintaining a "Market Perform" rating on the stock. This adjustment comes amidst other analyst revisions for Cummins, suggesting an evolving outlook for the company within the auto, truck, and motorcycle parts sector. The article also provides recent news headlines concerning Cummins' stock performance and other analyst actions.

**3. T1 Energy Inc: In Nov 2025, company and executive received voluntary document request from SEC - SEC filing**
- Source: marketscreener.com | 20251205T092500 | Somewhat-Bullish | Relevance: 63%
- T1 Energy Inc. announced that both the company and an executive received a voluntary document request from the SEC in November 2025, according to an SEC filing. This news was published on December 5, 2025, and provides an update on recent activities involving the energy company.

**4. Investors Pack Into CVS Ahead Of Make-Or-Break Update**
- Source: Finimize | 20251203T165133 | Neutral | Relevance: 63%
- CVS Health is approaching a critical investor day, with UBS noting the stock is "long crowded and well liked" due to anticipation of a multi-year recovery. The market is focused on margin recovery in its Health Care Benefits, how Caremark handles contract renewals, and the stabilization of the Pharmacy and Consumer Wellness business. While UBS anticipates conservative guidance, any disappointment could lead to a sell-off, whereas modest positive news could reinforce confidence in CVS's turnaround.

**5. CVS Health (NYSE: CVS) reports $474B U.S. economic impact, 1.3M jobs supported**
- Source: Stock Titan | 20251205T140857 | Neutral | Relevance: 62%
- CVS Health released its inaugural National Economic Impact Report, revealing an annual U.S. economic impact of $474 billion and supporting 1.3 million jobs nationwide. The report highlights CVS's extensive reach with 300,000+ employees, approximately 9,000 retail pharmacies, and over 1,000 clinics, serving 185 million individuals. Additionally, CVS Health contributed $58.6 billion in taxes and invested $239 million in community initiatives.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Bernstein | $294 | $346 | -15% |
| 2025-11-05 | Wells Fargo | $300 | $354 | -15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Bernstein | main | Market Perform |
| 2025-11-05 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($1.01M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+0.1%)
- Blackrock Inc.: 8.3% (-1.1%)
- JPMORGAN CHASE & CO: 5.0% (+106.4%)
- State Street Corpora: 4.5% (-1.2%)
- Price (T.Rowe) Assoc: 4.2% (+9.8%)

### Key Risks

1. Long-term trend broken: trading 12.6% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.56 indicates undervaluation relative to growth. Forward P/E 8.7x stretched relative to 3% growth. Balance sheet: $3.1B free cash flow. Analyst sentiment negative (2 target cuts vs 0 raises). Insider buying signal ($1.0M), management confidence. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $73.9B |
| Beta | 0.26 |
| 52W Range | $239.51 - $350.00 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.56 |
| Forward P/E | 8.7 |
| Current P/E | 9.0 |
| YoY Growth | 3.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.5% to -3.9% (-4.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.9pp (needs >4.0% for momentum thesis). Below SMA200 (0.87x), long-term trend not supportive. RSI neutral at 41. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.86% (CS: 19) | Weak |
| RSI_14 | 41.4 | Neutral |
| MACD Histogram | 0.29 | Bullish |
| vs SMA20 | 0.979x | Below |
| vs SMA50 | 0.937x | Below |
| vs SMA200 | 0.874x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $265.44
- **Stop Loss:** $250.28 (5.7% risk)
- **Target:** $295.76 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 32
- **Position Value:** $8,494.08
- **Portfolio %:** 8.49%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-05 (Est: $7.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.64 | $7.83 | +2.5% |
| 2025Q2 | $7.15 | $7.20 | +0.6% |
| 2025Q1 | $6.35 | $6.74 | +6.2% |
| 2024Q4 | $7.82 | $6.64 | -15.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*